Skip to main content

Peer Review reports

From: SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus

Original Submission
3 Oct 2011 Submitted Original manuscript
10 Oct 2011 Author responded Author comments - Chris Hurt
Resubmission - Version 2
10 Oct 2011 Submitted Manuscript version 2
28 Oct 2011 Editorially accepted
28 Oct 2011 Article published 10.1186/1471-2407-11-466

You can find further information about peer review here.

Back to article page